Greenland Mines (GRML) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Instil Bio (TIL) has outperformed Greenland Mines (GRML) over the past year, losing 60.2% versus a loss of 87.1%. Greenland Mines is the larger company by market cap ($44.3 million vs $35.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRML | TIL |
|---|---|---|
| Share price | $2.99 | $5.23 |
| Market cap | $44.31M | $35.47M |
| 1-day change | +2.75% | -5.77% |
| YTD return | -79.31% | -52.45% |
| 1-year return | -87.08% | -60.20% |
| 5-year return | — | -98.72% |
| EPS (TTM) | $-9.74 | $-3.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $10.77M |
| Revenue growth (YoY) | — | +152.38% |
| Net income (latest FY) | $-10.55M | $-71.37M |
| Operating margin | — | -745.39% |
| Net margin | — | -662.75% |
| 52-week high | $37.00 | $12.92 |
| 52-week low | $2.75 | $5.14 |
| Distance from 52-week high | -91.92% | -59.51% |
| Analyst consensus | none | none |
| Avg. price target upside | +3578.93% | +33.84% |
| Average volume | 8.93M | 42.02K |
| Shares outstanding | 14.82M | 6.78M |
| Employees | 5 | 17 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TIL has outperformed GRML by 26.9 percentage points over the past year.
About Greenland Mines
GRML stock →Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 5 employees
About Instil Bio
TIL stock →Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 17 employees
GRML vs TIL FAQ
Which is bigger, Greenland Mines or Instil Bio?
Greenland Mines (GRML) is larger, with a market capitalization of $44.31M compared with $35.47M for Instil Bio (TIL).
Which stock has performed better over the past year, GRML or TIL?
TIL returned -60.20% over the past 12 months, compared with -87.08% for GRML (price return, excluding dividends). Past performance does not predict future results.
Are Greenland Mines and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.